Stockscreener 앱 받기
1.84
0.54%
-0.01
전일 마감가:
$1.85
열려 있는:
$1.83
하루 거래량:
8,483
Relative Volume:
0.32
시가총액:
$10.03M
수익:
$2.35M
순이익/손실:
$-2.56M
주가수익비율:
-4.1062
EPS:
-0.4481
순현금흐름:
-
1주 성능:
+0.29%
1개월 성능:
+3.90%
6개월 성능:
-8.00%
1년 성능:
-23.97%
1일 변동 폭
$1.83
$1.89
1주일 범위
$1.81
$1.94
52주 변동 폭
$1.50
$2.87
이뮤론 Stock (IMRN) Company Profile
IMRN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IMRN
Immuron Limited Adr
|
1.88 | 10.03M | 2.35M | -2.56M | 0 | -0.4481 |
|
VRTX
Vertex Pharmaceuticals Inc
|
440.46 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
521.58 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
324.84 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
559.98 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
244.34 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
이뮤론 주식(IMRN)의 최신 뉴스
immuron ltd files for quotation of securities on ASX By Investing.com - Investing.com South Africa
immuron ltd files for quotation of securities on ASX - Investing.com
Immuron Letter to Shareholders: Projects Update - GlobeNewswire Inc.
Immuron and Calmino join up to treat Irritable Bowel Syndrome (IBS) - Markets Insider
Immuron: Targeted oral antibodies to treat infectious diseases - Innovation News Network
NMRC Reports Results for Campylobacter Controlled Human Infection Model Study - GlobeNewswire
Immuron: US FDA provides favourable feedback ahead of investigational new drug application for IMM-529 - Proactive financial news
Immuron requests pre-IND meeting for IMM-529 with FDA filing - GlobeNewswire
Why PriceSmart Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket - Markets Insider
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.34% - Investing.com UK
Immuron Limited Announces Participation in the LD Micro Invitational XIII - The Kingston Whig-Standard
Immuron Surges On U.S. DoD Funding For Travelan Research By Investing.com - Investing.com Nigeria
Immuron US DoD Naval Medical Research Center Receives feedback on IND Application for New Campylobacter ETEC Therapeutic - StockTitan
Immuron LimitedADR Shares Close the Week 61.5% HigherWeekly Wrap - Nasdaq
IMRNImmuron Ltd Latest Stock News & Market Updates - Stock Titan
Immuron Limited Trade Ideas — NASDAQ:IMRN - TradingView
IMC Reports Rising Revenues & Eyes Colitis Market - Next Investors
IMC Stock Price and Chart — ASX:IMC - TradingView
이뮤론 (IMRN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.05%
0.00%
자본화:
|
볼륨(24시간):